This week's Fierce LifeSci Weekly is brought to you by Altasciences.
This session will offer a look into how various validated models of pain, anxiety, and other psychiatric conditions can be tactically incorporated into early testing batteries of cognition and safety to evaluate a drug’s potential for abuse or dependence, as well as its ability to enhance or impair performance. Customized approaches that can be adapted to major therapeutic areas will also be reviewed.
- Learn about various pharmacodynamic models that can provide early indicators of efficacy;
- Discover how pharmacodynamic models can facilitate the rapid identification of targeted clinical benefits in patient populations;
- Consider specialized models (eg, cold pressor test, CO2 challenge test) that can inform clinical development decisions;
- Learn how various cognitive, subjective, and physiological endpoints can converge to augment the knowledge about the safety, efficacy, and PK profile of the study drug; and
- Recognize how early pharmacodynamic testing can help with strategic product differentiation and funding opportunities.
|
| You are currently subscribed as newsletter@newslettercollector.com |
